The research company Curasight has, after approval at an extraordinary general meeting, decided to issue a convertible note to Fenja Capital under a previously communicated loan agreement. The total loan facility amounts to SEK 40 million and is divided into two tranches, with the first, of SEK 25 million, structured as a convertible loan. Of this first tranche, SEK 10 million is for refinancing an existing loan, while SEK 15 million is disbursed in connection with today's decision. The second tranche of SEK 15 million can be utilized during the second quarter of 2026.